Biohaven Ltd.
15.00USD
+0.2800 (+1.90%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | — | — | — | — | 25.0M | 25.5M |
| Q1 | — | — | — | — | — | — |
| Q2 | — | — | — | — | — | — |
| Q3 | — | — | — | — | 25.0M | — |
| Q4 | — | — | — | — | 0.0 | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -12.75 | -5.73 | -9.28 | -6.86 | -1.97 | -1.94 |
| Q1 | -2.46 | -1.03 | -2.20 | -2.17 | -.880 | — |
| Q2 | -5.16 | -1.32 | -3.64 | -1.94 | -.910 | — |
| Q3 | -1.75 | -1.50 | -1.70 | -1.64 | -.205 | — |
| Q4 | -4.49* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -2.03* |
| -2.05* |
| -1.35* |
| -.462 |
| — |